Jnson Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-06-2024
- Paid Up Capital ₹ 1.00 M
as on 26-06-2024
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.30 M
as on 26-06-2024
- Revenue -1.07%
(FY 2021)
- Profit 208.62%
(FY 2021)
- Ebitda 0.01%
(FY 2021)
- Net Worth 3.38%
(FY 2021)
- Total Assets 7.60%
(FY 2021)
About Jnson Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹0.30 M.
Varun Bhatia, Subhash Bhatia, and Kanta Bhatia serve as directors at the Company.
- CIN/LLPIN
U24231HR1995PTC032770
- Company No.
032770
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationHaryana, Haryana
- Telephone
- Email Address
- Website
- Social Media
What products or services does Jnson Laboratories Private Limited offer?
Jnson Laboratories Private Limited offers a wide range of products and services, including Camphor, Camphor Tablet, Homeopathic Drugs, Homoeopathic Syrup, Nutraceuticals & Dietary Supplements, Fitness Supplements, Dentist Tools, Equipment & Supplies, Oral Care Kit, Pharmaceutical Tablets, Homoeopathic Drops.
Who are the key members and board of directors at Jnson Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Bhatia  | Managing Director | 19-Jul-1995 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varun Bhatia | Director | 01-Sep-2021 | Current |
| Kanta Bhatia | Director | 01-Jan-2009 | Current |
Financial Performance and Corporate Structure Insights of Jnson Laboratories.
Jnson Laboratories Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 1.07% decrease. The company also saw a substantial improvement in profitability, with a 208.62% increase in profit. The company's net worth moved up by a moderate rise of 3.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jnson Laboratories?
In 2021, Jnson Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjasb National Bank Creation Date: 21 Dec 1995 | ₹0.30 M | Open |
How Many Employees Work at Jnson Laboratories?
Unlock and access historical data on people associated with Jnson Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jnson Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jnson Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
